vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and BROOKFIELD Corp (BN). Click either name above to swap in a different company.
BROOKFIELD Corp is the larger business by last-quarter revenue ($18.1B vs $14.5B, roughly 1.3× ASTRAZENECA PLC). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 5.8%, a 11.1% gap on every dollar of revenue.
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Brookfield Properties is a North American subsidiary of commercial real estate firm Brookfield Property Partners, which itself is a subsidiary of alternative asset management company Brookfield Corporation. It is responsible for the asset management of the company's real estate portfolio, including office, multi-family residential, retail, hospitality, and logistics buildings.
AZN vs BN — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $18.1B |
| Net Profit | $2.4B | $1.1B |
| Gross Margin | 82.9% | — |
| Operating Margin | 24.3% | — |
| Net Margin | 16.9% | 5.8% |
| Revenue YoY | 11.7% | — |
| Net Profit YoY | 27.0% | — |
| EPS (diluted) | $1.57 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $14.5B | $18.1B | ||
| Q2 24 | $12.9B | — | ||
| Q2 23 | $11.4B | $23.7B | ||
| Q2 22 | $10.8B | $23.3B |
| Q2 25 | $2.4B | $1.1B | ||
| Q2 24 | $1.9B | — | ||
| Q2 23 | $1.8B | $1.5B | ||
| Q2 22 | $360.0M | $1.5B |
| Q2 25 | 82.9% | — | ||
| Q2 24 | 83.1% | — | ||
| Q2 23 | 82.8% | — | ||
| Q2 22 | 72.2% | — |
| Q2 25 | 24.3% | — | ||
| Q2 24 | 21.2% | — | ||
| Q2 23 | 21.5% | — | ||
| Q2 22 | 5.0% | — |
| Q2 25 | 16.9% | 5.8% | ||
| Q2 24 | 14.9% | — | ||
| Q2 23 | 15.9% | 6.4% | ||
| Q2 22 | 3.3% | 6.3% |
| Q2 25 | $1.57 | $0.15 | ||
| Q2 24 | $1.24 | — | ||
| Q2 23 | $1.17 | $0.03 | ||
| Q2 22 | $0.23 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $13.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8B | $161.6B |
| Total Assets | $112.4B | $506.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $7.1B | $13.7B | ||
| Q2 24 | $6.9B | — | ||
| Q2 23 | $5.7B | $12.4B | ||
| Q2 22 | $4.8B | $12.2B |
| Q2 25 | $44.8B | $161.6B | ||
| Q2 24 | $39.6B | — | ||
| Q2 23 | $37.4B | $155.6B | ||
| Q2 22 | $36.0B | $134.0B |
| Q2 25 | $112.4B | $506.1B | ||
| Q2 24 | $104.3B | — | ||
| Q2 23 | $96.5B | $463.1B | ||
| Q2 22 | $96.6B | $411.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.0B |
| Free Cash FlowOCF − Capex | — | $-745.0M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | — | 15.2% |
| Cash ConversionOCF / Net Profit | — | 1.91× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $2.0B | ||
| Q2 24 | — | — | ||
| Q2 23 | — | $406.0M | ||
| Q2 22 | — | $3.1B |
| Q2 25 | — | $-745.0M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | $-1.2B | ||
| Q2 22 | — | $1.5B |
| Q2 25 | — | -4.1% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | -5.3% | ||
| Q2 22 | — | 6.3% |
| Q2 25 | — | 15.2% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | 7.0% | ||
| Q2 22 | — | 7.1% |
| Q2 25 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q2 23 | — | 0.27× | ||
| Q2 22 | — | 2.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
